Type 1 Diabetes

TRIGR logo

TRIGR (Trial to Reduce IDDM in the Genetically at Risk) is an international, randomized, double-blinded trial. The hypothesis to be tested is whether hydrolyzed infant formula compared to cow's milk-based formula decreases risk of developing type 1 diabetes in children with increased genetic susceptibility. Recruitment and study visits are completed; no more babies will be enrolled.

Click for more
can we protect our children?

Announcements

          TRIGR Study Team announces the final result of the research.  Learn more >     See also >

          Ancillary Studies information now available. Learn More >


          Information for TRIGR participants: (.pdf) (.docx)


         TRIGR Parents:

              ◊ The Asthma and Allergy Study's survey has closed to participation. Many thanks to the TRIGR parents who did the survey!

              ◊ The TRIGR Follow Up Study has closed to participation. Many thanks to the TRIGR parents who participated!


For more information about this study in your country, please click on your flag:

Australia Canada Czech Republic Estonia Finland Germany Hungary Italy Luxembourg Netherlands Poland Spain Sweden Switzerland United States

TRIGR is Sponsored By:

We acknowledge support from the
EC 5th Framework Programme
via project QLK1 CT 2002 00372
Diabetes Prevention
   


Study Formula Provided By:

Mead Johnson Nutritionals

 

 
Australia Canada Czech Rebublic Estonia Finland Germany Hungary Italy Luxembourg Netherlands Poland Spain Sweden Switzerland United States